IDiyas

For the Inventor, By the Inventor

New Delhi, India

Jag Mohan Khanna

USPTO Granted Patents = 15

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • New Delhi, IN (1991 - 1999)
  • Haryana, IN (1999)
  • Gurgaon, IN (2001)

Company Filing History:

goldMedal15 out of 157 
 
Ranbaxy Laboratories, Inc.
 patents

Years Active: 1991-2001

Loading Chart...
15 patents (USPTO):Explore Patents
1. 6235896 - Process for the preparation of cefuroxime (2001-05-22),
2. 5939564 - Process of lactonization in the preparation of statins (1999-08-17),
3. 5917058 - Process of lactonization in the preparation of statins (1999-06-29),
4. 5869649 - Process for producing cephalosporin antibiotics (1999-02-09),
5. 5792874 - Process for the manufacture of (1998-08-11),
6. 5763653 - Key intermediates in the manufacture of simvastatin (1998-06-09),
7. 5763646 - Process for manufacturing simvastatin from lovastatin or mevinolinic acid (1998-06-09),
8. 5756729 - Process for the manufacture of 8-chloro-6 (2-fluorophenyl)-1 (1998-05-26),
9. 5696275 - Process for the manufacture of pharmaceutical grade ranitidine base (1997-12-09),
10. 5621120 - Process for the manufacture of form 1 ranitidine hydrochloride (1997-04-15),
11. 5536830 - Process for P-nitrobenzyl ester cleavage in cephalosporin (1996-07-16),
12. 5410044 - Process for preparing Z and E-rotamers of 3-hydroxy cephem derivatives (1995-04-25),
13. 5347000 - Process for the preparation of 2-chlorosulfinylazetidinone (1994-09-13),
14. 5159071 - Process for the manufacture of (1992-10-27),
15. 5070195 - Ring-opening process for preparation of 2-chlorosulfinyl azetidinones (1991-12-03),

Title: Profile of Inventor Jag Mohan Khanna: Innovator in Pharmaceutical Chemistry

Introduction: Jag Mohan Khanna is a distinguished inventor based in New Delhi, India, known for his significant contributions to pharmaceutical chemistry. With an impressive portfolio of 15 patents, his work primarily revolves around novel processes in the synthesis of essential medications.

Latest Patents: Khanna's latest innovations include two notable patents. The first is a method for the preparation of cefuroxime, wherein a process is described for deriving cefuroxime from predominantly S-cefuroxime axetil, or other mixtures not meeting purity standards. This process involves treating cefuroxime axetil with alkoxides in a suitable solvent mixture and successfully isolating cefuroxime from the reaction mix. The second patent details a novel lactonization process in the preparation of statins, such as the HMG-CoA reductase inhibitors lovastatin and simvastatin. This method emphasizes mild reaction conditions, utilizing a solution of hydroxy acids in organic solvents under anhydrous conditions, which promotes the crystallization of statins in their lactone form upon water addition.

Career Highlights: Jag Mohan Khanna currently works at Ranbaxy Laboratories, Inc., a prominent company in the pharmaceutical industry. During his career, he has focused on research and development aimed at enhancing drug formulation and production processes, contributing significantly to the advancement of pharmaceutical sciences.

Collaborations: Throughout his career, Khanna has collaborated with noted professionals in his field, including coworkers Yatendra Kumar and Naresh Kumar. Their combined expertise has fostered innovation and improved processes in pharmaceutical development.

Conclusion: Jag Mohan Khanna's work exemplifies the innovative spirit that drives advancements in medicine. With his extensive array of patents and collaborative efforts, he continues to make valuable contributions to the field of pharmaceutical chemistry, enhancing the potential for creating effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…